General Updates

July 16, 2026 CS&G/STX/SQ2026/08 1) National Stock Exchange of India Limited 2) BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Scrip Symbol: KFINTECH Scrip Code: 543720 Sub. : Updates on Investment in KFin Technologies (Singapore) Pte. Ltd., wholly owned subsidiary of the Company Ref. : Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”) Dear Sir / Madam, Further to our previous intimation bearing reference no. CS&G/STX/JQ2026/28 dated June 10, 2026, wherein it was informed that the Board of Directors of the Company had, at its meeting held on June 10, 2026, inter-alia approved the proposal for further capital infusion in KFin Technologies (Singapore) Pte. Ltd., a wholly owned subsidiary of the Company (“KFin Singapore”), along with the necessary details as required under the LODR Regulations read with SEBI’s Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Pursuant to Regulation 30 and other applicable provisions of the LODR Regulations, and further to the aforesaid approval, the Company has today, i.e., July 16, 2026, remitted an aggregate amount equal to USD 1,999,999.20 towards the capital infusion in KFin Singapore. Details as per BSE’s Circular No. 20230714-34 dated July 14, 2023, and NSE’s Circular No. NSE /CML/2023/57 dated July 14, 2023, are as under: Date of occurrence of event / information July 16, 2026 Time of occurrence of event / information At around 12:01 p.m. IST This is for your information and records. Thanking you, Yours faithfully, For KFin Technologies Limited Alpana Kundu Company Secretary and Compliance Officer ICSI Membership No.: F10191